InvestorsHub Logo
Followers 25
Posts 2057
Boards Moderated 0
Alias Born 12/18/2012

Re: None

Thursday, 04/20/2017 5:38:16 PM

Thursday, April 20, 2017 5:38:16 PM

Post# of 17446
WOW!! Music to my ears!! “We are pleased by the recognition of the medical and scientific communities of the AURA study results. Beyond the remission rates we’ve shown with voclosporin, the significant improvement in SLEDAI scores points towards a durable, immunological effect on a broad range of clinically meaningful lupus outcomes,” said Neil Solomons, MD, Aurinia’s Chief Medical Officer. “This data provides us with tremendous confidence that we can execute a successful Phase III program and make a meaningful impact on patients’ lives.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News